
Israel has 1,800 life-sciences companies but almost no blockbuster drugs. This ecosystem includes Teva, InMode, AI health, Weizmann IP, and aMoon capi…
Israel Real Economy · 22 stories · Updated Aug 14, 2026
Lead storyIsrael has 1,800 life-sciences companies but almost no blockbuster drugs. This ecosystem includes Teva, InMode, AI health, Weizmann IP, and aMoon capital.
Read →Deeper coverage tracks inside Health & Biotech
Teva, Taro, Dexcel, Perrigo
Israeli device makers develop tools for surgery, imaging and treatment, while acquisitions connect local businesses with…
Israeli digital health companies: software for remote consultations, triage and medical imaging, and the health systems…
Sciences Venture Capital: aMoon, Pontifax, Israel Biotech Fund, OrbiMed
Long-form reference entries in Health & Biotech
The Weizmann Institute's tech transfer arm earned more than $1.5bn in royalties on a single multiple sclerosis drug. The…
Yeda — the Weizmann Institute's tech-transfer arm — is the prototype Israeli university commercialisation vehicle. Its l…
Page 1 of 3

Israel has 1,800 life-sciences companies but almost no blockbuster drugs. This ecosystem includes Teva, InMode, AI health, Weizmann IP, and aMoon capi…

Israel's four health funds—Clalit, Maccabi, Meuhedet, and Leumit—are non-profits. Two of them control for-profit hospital networks worth hundreds of m…

Clalit's Petah Tikva tertiary flagship (Rabin Medical Center) and Israel's #1 transplant center. Top-tier in the hospitals Answer Index — everywhere,…

Sheba ARC — the innovation arm of Sheba Medical Center. Founded 2019 by Prof. Eyal Zimlichman. 100+ startups, 3 unicorns, $1B+ invested, 160 FTEs — th…
RedHill Biopharma (Nasdaq: RDHL). Founded 2009 by Dror Ben-Asher. Tel Aviv HQ, Raleigh operations. Talicia (H. pylori), opaganib (oncology/infectious…

Leumit Health Services is the smallest of Israel's four statutory health funds — ~730,000 members, ~300 clinics, ~100 pharmacies, ~ILS 4B annual budge…

InMode, founded by Moshe Mizrahy and Dr. Michael Kreindel, is an Israeli medical-aesthetic device maker. It uses proprietary radiofrequency technology…

Compugen (Nasdaq: CGEN; TASE: CGEN) — Israeli immuno-oncology and predictive drug-discovery pioneer. Founded 1993 by Eli Mintz, Simchon Faigler, Amir…

Teva paid $40.5 billion for Allergan Generics in 2016 and watched approximately $50 billion in market value evaporate. Eight years and three CEOs late…